Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Sees Large Decline in Short Interest

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) was the target of a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 354 shares, a drop of 91.2% from the January 29th total of 4,007 shares. Based on an average daily trading volume, of 16,117 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 16,117 shares, the days-to-cover ratio is currently 0.0 days.

Coeptis Therapeutics Price Performance

COEPW opened at $0.01 on Thursday. Coeptis Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.05. The company’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.02.

Coeptis Therapeutics Company Profile

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.